CARNIVAL CORP (CCL)

PA1436583006 - Common Stock

26.8  +1.62 (+6.43%)

After market: 26.8101 +0.01 (+0.04%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CCL. CCL was compared to 134 industry peers in the Hotels, Restaurants & Leisure industry. While CCL is still in line with the averages on profitability rating, there are concerns on its financial health. CCL has a correct valuation and a medium growth rate.



4

1. Profitability

1.1 Basic Checks

In the past year CCL was profitable.
In the past year CCL had a positive cash flow from operations.
CCL had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CCL reported negative operating cash flow in multiple years.

1.2 Ratios

CCL has a Return On Assets (3.14%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 18.20%, CCL is in the better half of the industry, outperforming 77.61% of the companies in the same industry.
CCL has a Return On Invested Capital (7.15%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 3.14%
ROE 18.2%
ROIC 7.15%
ROA(3y)-9.92%
ROA(5y)-8.44%
ROE(3y)-55.18%
ROE(5y)-40.71%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CCL has a Profit Margin of 6.39%. This is in the better half of the industry: CCL outperforms 64.18% of its industry peers.
Looking at the Operating Margin, with a value of 13.88%, CCL is in the better half of the industry, outperforming 64.18% of the companies in the same industry.
CCL's Operating Margin has declined in the last couple of years.
CCL has a Gross Margin (51.97%) which is comparable to the rest of the industry.
CCL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.88%
PM (TTM) 6.39%
GM 51.97%
OM growth 3YN/A
OM growth 5Y-12.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.2%
GM growth 5Y3.73%

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CCL is destroying value.
CCL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CCL has more shares outstanding
The debt/assets ratio for CCL has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.04, we must say that CCL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CCL (1.04) is worse than 64.93% of its industry peers.
CCL has a debt to FCF ratio of 23.59. This is a negative value and a sign of low solvency as CCL would need 23.59 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 23.59, CCL is in line with its industry, outperforming 44.78% of the companies in the same industry.
CCL has a Debt/Equity ratio of 3.10. This is a high value indicating a heavy dependency on external financing.
CCL's Debt to Equity ratio of 3.10 is in line compared to the rest of the industry. CCL outperforms 48.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.1
Debt/FCF 23.59
Altman-Z 1.04
ROIC/WACC0.9
WACC7.97%

2.3 Liquidity

CCL has a Current Ratio of 0.30. This is a bad value and indicates that CCL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.30, CCL is not doing good in the industry: 93.28% of the companies in the same industry are doing better.
CCL has a Quick Ratio of 0.30. This is a bad value and indicates that CCL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.26, CCL is not doing good in the industry: 91.79% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.3
Quick Ratio 0.26

5

3. Growth

3.1 Past

CCL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 237.65%, which is quite impressive.
Looking at the last year, CCL shows a very strong growth in Revenue. The Revenue has grown by 22.18%.
The Revenue has been growing slightly by 2.72% on average over the past years.
EPS 1Y (TTM)237.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.67%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y56.86%
Revenue growth 5Y2.72%
Sales Q2Q%15.2%

3.2 Future

Based on estimates for the next years, CCL will show a very strong growth in Earnings Per Share. The EPS will grow by 110.93% on average per year.
CCL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.98% yearly.
EPS Next Y2008.97%
EPS Next 2Y418.01%
EPS Next 3Y212.83%
EPS Next 5Y110.93%
Revenue Next Year16.3%
Revenue Next 2Y10.19%
Revenue Next 3Y7.89%
Revenue Next 5Y5.98%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 22.91 indicates a rather expensive valuation of CCL.
Based on the Price/Earnings ratio, CCL is valued a bit cheaper than 67.16% of the companies in the same industry.
When comparing the Price/Earnings ratio of CCL to the average of the S&P500 Index (27.73), we can say CCL is valued inline with the index average.
With a Price/Forward Earnings ratio of 15.42, CCL is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CCL indicates a rather cheap valuation: CCL is cheaper than 80.60% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CCL to the average of the S&P500 Index (22.83), we can say CCL is valued slightly cheaper.
Industry RankSector Rank
PE 22.91
Fwd PE 15.42

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CCL is valued a bit cheaper than the industry average as 67.91% of the companies are valued more expensively.
CCL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CCL is cheaper than 68.66% of the companies in the same industry.
Industry RankSector Rank
P/FCF 28.46
EV/EBITDA 10.19

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CCL's earnings are expected to grow with 212.83% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y418.01%
EPS Next 3Y212.83%

0

5. Dividend

5.1 Amount

No dividends for CCL!.
Industry RankSector Rank
Dividend Yield N/A

CARNIVAL CORP

NYSE:CCL (12/20/2024, 8:04:00 PM)

After market: 26.8101 +0.01 (+0.04%)

26.8

+1.62 (+6.43%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)09-30 2024-09-30/bmo
Earnings (Next)12-20 2024-12-20/bmo
Inst Owners52.36%
Inst Owner Change1.54%
Ins Owners6.66%
Ins Owner Change-0.02%
Market Cap34.81B
Analysts80
Price Target25.27 (-5.71%)
Short Float %6.28%
Short Ratio2.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)383.54%
Min EPS beat(2)8.2%
Max EPS beat(2)758.87%
EPS beat(4)4
Avg EPS beat(4)208.79%
Min EPS beat(4)8.2%
Max EPS beat(4)758.87%
EPS beat(8)8
Avg EPS beat(8)108.9%
EPS beat(12)8
Avg EPS beat(12)40.95%
EPS beat(16)8
Avg EPS beat(16)27.79%
Revenue beat(2)1
Avg Revenue beat(2)0.32%
Min Revenue beat(2)-0.1%
Max Revenue beat(2)0.75%
Revenue beat(4)2
Avg Revenue beat(4)0%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)0.75%
Revenue beat(8)5
Avg Revenue beat(8)0.23%
Revenue beat(12)5
Avg Revenue beat(12)-5.3%
Revenue beat(16)5
Avg Revenue beat(16)-19.93%
PT rev (1m)4.2%
PT rev (3m)12.81%
EPS NQ rev (1m)6.32%
EPS NQ rev (3m)112.1%
EPS NY rev (1m)0%
EPS NY rev (3m)10.77%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)2.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.54%
Valuation
Industry RankSector Rank
PE 22.91
Fwd PE 15.42
P/S 1.42
P/FCF 28.46
P/OCF 5.87
P/B 4.05
P/tB 5.09
EV/EBITDA 10.19
EPS(TTM)1.17
EY4.37%
EPS(NY)1.74
Fwd EY6.49%
FCF(TTM)0.94
FCFY3.51%
OCF(TTM)4.57
OCFY17.04%
SpS18.84
BVpS6.62
TBVpS5.27
PEG (NY)0.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.14%
ROE 18.2%
ROCE 9.05%
ROIC 7.15%
ROICexc 7.45%
ROICexgc 7.83%
OM 13.88%
PM (TTM) 6.39%
GM 51.97%
FCFM 5%
ROA(3y)-9.92%
ROA(5y)-8.44%
ROE(3y)-55.18%
ROE(5y)-40.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-12.64%
ROICexc growth 3YN/A
ROICexc growth 5Y-11.2%
OM growth 3YN/A
OM growth 5Y-12.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.2%
GM growth 5Y3.73%
F-Score7
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 3.1
Debt/FCF 23.59
Debt/EBITDA 4.52
Cap/Depr 188.81%
Cap/Sales 19.24%
Interest Coverage 250
Cash Conversion 100.68%
Profit Quality 78.15%
Current Ratio 0.3
Quick Ratio 0.26
Altman-Z 1.04
F-Score7
WACC7.97%
ROIC/WACC0.9
Cap/Depr(3y)172.41%
Cap/Depr(5y)186.02%
Cap/Sales(3y)81.62%
Cap/Sales(5y)67.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)237.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.67%
EPS Next Y2008.97%
EPS Next 2Y418.01%
EPS Next 3Y212.83%
EPS Next 5Y110.93%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y56.86%
Revenue growth 5Y2.72%
Sales Q2Q%15.2%
Revenue Next Year16.3%
Revenue Next 2Y10.19%
Revenue Next 3Y7.89%
Revenue Next 5Y5.98%
EBIT growth 1Y291.02%
EBIT growth 3YN/A
EBIT growth 5Y-10.07%
EBIT Next Year239.55%
EBIT Next 3Y57.55%
EBIT Next 5Y33.3%
FCF growth 1Y119.83%
FCF growth 3YN/A
FCF growth 5Y-11.14%
OCF growth 1Y408.8%
OCF growth 3YN/A
OCF growth 5Y-5.06%